(All fields required)
Please enter a valid email.
Please enter your name.
A pathway to preventing peripheral neuropathy?
Study published in Nature Communications suggests that preserving the normal function of a tumor suppression gene could reduce complications of diabetes, Guillain-Barré syndrome and other nerve-damaging conditions. Read more.
And that's just one of several ways current and former players are supporting Cincinnati Children's. Read More »
Lab created to re-analyze blood sample cards for signs of sickle cell disease. Watch the video »
$1.6M grant to Cincinnati Children's is part of a wider FDA focus on rare diseases. Read more »
Study published in the Journal of Allergy and Clinical Immunology characterizes rare, painful disorder. Read more »
In mice, gene-corrected macrophages successfully treat rare lung condition. Read more »
Federal Healthy Start grant supports widescale community collaboration. Read more »
New technology makes it easier than ever to gain access to experts at Cincinnati Children's.Read more »
With a goal of $250 million, the Change the Outcome Campaign is the most ambitious philanthropic effort in our history. Read more »
Register today for Pediatric Insights, our monthly e-newsletter for physicians. Receive the latest information on clinical advancements, research updates and news from Cincinnati Children's.
Subscribe Now >>
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center